Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Telo Genomics Corp V.TELO

Alternate Symbol(s):  TDSGF

Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSXV:TELO)

Fundamentals Snapshot (TSXV:TELO)

Opinion & Analysis (TSXV:TELO)

No current opinion is available.

Bullboard Posts (TSXV:TELO)

Telo Announces Validation of Its Proprietary Tools for SMM

Telo Genomics Announces Successful Validation of Its Proprietary Automation Tools for Smoldering Multiple Myeloma Toronto, Ontario...
toasted101 - May 31, 2022

huge volume

Something good must be up for this volume of today.
bandi10 - April 11, 2022

Telo Clinical Validation of its Smoldering Myeloma Test

Telo Genomics Launches Clinical Validation of its Smoldering Multiple Myeloma Diagnostic Test Toronto, Ontario--(Newsfile Corp...
toasted101 - March 7, 2022

RE:news

Dr. McGlennen is a strong addition to the Telo team that should prove beneficial in taking Telo to commercialization. http://www.telodx...
toasted101 - February 3, 2022

news

Telo Genomics Appoints Dr. McGlennen as Board Director, a Leader in Commercializing Novel Diagnostic Technologies Toronto, Ontario...
bandi10 - February 3, 2022

Telo Genomics Advances Its Lead Product

Telo Genomics Advances Its Lead Product and Implements Automation to Its Workflow Toronto, Ontario--(Newsfile Corp. - January 19...
toasted101 - January 19, 2022